Added to YB: 2020-02-23
Pitch date: 2020-02-23
AXNX [bullish]
Axonics, Inc.
+103.73%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Axonics, Inc. develops therapies for urinary and bowel dysfunction. The company provides therapies and solutions for these conditions, offering the Axonics System for healthcare professionals and patients.
Market Cap
$3.6B
Pitch Price
$34.84
Price Target
N/A
Dividend
N/A
EV/EBITDA
352.92
P/E
-634.68
EV/Sales
7.68
Sector
Health Care Equipment and Supplies
Category
N/A
Show full summary:
Axonics AXNX
A summary for this pitch has not been created yet.
Read full article (0 min)